“…Autoimmune lymphoproliferative syndrome (ALPS) is characterized by nonmalignant organomegaly, immune cytopenia, and an increased risk for lymphoma, as well as mutation in the FAS -mediated apoptotic pathway [ 1 , 2 , 3 , 4 , 5 , 6 , 7 , 8 , 9 , 10 ]. Few studies have considered the identification of ALPS in certain populations, such as patients with Evans syndrome or lymphoma [ 11 , 12 , 13 , 14 , 15 , 16 ].…”